Search Medical Condition
Please enter condition
Please choose location from dropdown

Migraine (Pediatric) Clinical Trials

A listing of Migraine (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (20) clinical trials

To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years. Eligibility Criteria: Each child must have a responsible trained adult with knowledge of the conduct of the study and must be available to supervise migraine ...

Phase

The objective of the study is to evaluate the safety and efficacy of ONZETRA Xsail (AVP-825) compared to placebo in the acute treatment of migraine in adolescent patients, 12 through 17 years of age.

Phase

If the answer to this question is yes, and your child is 12-17 years of age, and experiences two or more migraine headaches a month, he or she may be eligible to join a clinical research study looking at an investigational treatment for migraine headaches. The study will involve 3-4 ...

Phase N/A

The main purpose of this study is to determine the safety and efficacy of the study drug galcanezumab in participants 6 to 17 years of age with episodic migraine.

Phase

John E. Ervin, M.D. is conducting a research study for adolescents with a history of acute episodic migraines.

Phase

Testing an investigational medication for migraine headaches

Phase

This is a 28-week study requiring a total of 3 clinic visits. Subjects will be treated with either a placebo or the study drug which will be given intranasally (inhaled through the nose).

Phase N/A

The objective of the study is to evaluate the safety and efficacy of ONZETRA Xsail (AVP-825) compared to placebo in the acute treatment of migraine in adolescent patients, 12 through 17 years of age.

Phase

Access Clinical Trials, Inc in Nashville TN is conducting  a randomized, double-blind, placebo-controlled, crossover study to evaluate the efficacy and safety of Zolmitriptan Nasal Spray for the treatment of acute migraine in subjects ages 6 to 11 years old. Study has an open label extension.

Phase

Does your child get migraines? The purpose of this research study is to measure how effective and how safe investigational zolmitriptan nasal spray is for acute migraine headaches in children ages 6 to 11 years old. This study requires up to 7 visits over 11 months.

Phase